Cargando…
Correction to: Revefenacin: First Global Approval
Autor principal: | Heo, Young-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483947/ https://www.ncbi.nlm.nih.gov/pubmed/30927162 http://dx.doi.org/10.1007/s40265-019-01106-z |
Ejemplares similares
-
Revefenacin: First Global Approval
por: Heo, Young-A
Publicado: (2018) -
Correction to: Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018) -
Correction to: Satralizumab: First Approval
por: Heo, Young-A
Publicado: (2020) -
Correction to: Efgartigimod: First Approval
por: Heo, Young-A
Publicado: (2022) -
Correction to: Fremanezumab: First Global Approval
por: Hoy, Sheridan M.
Publicado: (2019)